XML 15 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Changes in Equity and Income (unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Total
Select Medical Corporation
Common Stock
Common Stock
Select Medical Corporation
Capital in Excess of Par
Capital in Excess of Par
Select Medical Corporation
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Select Medical Corporation
Total Stockholders’ Equity
Total Stockholders’ Equity
Select Medical Corporation
Non-controlling Interests
Non-controlling Interests
Select Medical Corporation
Balance at Dec. 31, 2017 $ 640,818 $ 640,818                    
Redeemable Non-controlling Interests                        
Net income attributable to non-controlling interests 25,896 25,896                    
Issuance and exchange of non-controlling interests 163,659 163,659                    
Distributions to and purchases of non-controlling interests (215,847) (215,847)                    
Redemption adjustment on non-controlling interests 164,065 164,065                    
Other 983 983                    
Balance at Sep. 30, 2018 $ 779,574 $ 779,574                    
Balance (in shares) at Dec. 31, 2017 134,114,715 100 134,115,000 0                
Balance at Dec. 31, 2017 $ 932,604 $ 932,604 $ 134 $ 0 $ 463,499 $ 947,370 $ 359,735 $ (124,002) $ 823,368 $ 823,368 $ 109,236 $ 109,236
Increase (Decrease) in Stockholders' Equity                        
Net income 113,167 113,167         113,167 113,167 113,167 113,167    
Net income attributable to non-controlling interests 8,157 8,157                 8,157 8,157
Issuance of restricted stock (in shares)     1,222,000                  
Issuance of restricted stock 0   $ 1   (1)              
Forfeitures of unvested restricted stock (in shares)     (88,000)                  
Forfeitures of unvested restricted stock 0   $ 0   0              
Vesting of restricted stock 15,059       15,059       15,059      
Repurchase of common shares (in shares)     (285,000)                  
Repurchase of common shares (5,640)   $ 0   (2,989)   (2,651)   (5,640)      
Exercise of stock options (in shares)     176,000                  
Exercise of stock options 1,633   $ 0   1,633       1,633      
Additional investment by Holdings   1,633       1,633       1,633    
Dividends declared and paid to Holdings   (5,640)           (5,640)   (5,640)    
Contribution related to restricted stock award issuances by Holdings   15,059       15,059       15,059    
Issuance and exchange of non-controlling interests 77,815 77,815     1,553 1,553 74,341 74,341 75,894 75,894 1,921 1,921
Distributions to and purchases of non-controlling interests (92,020) (92,020)     (932) (932) (83,617) (83,617) (84,549) (84,549) (7,471) (7,471)
Redemption adjustment on non-controlling interests (164,065) (164,065)         (164,065) (164,065) (164,065) (164,065)    
Other $ 858 $ 858         (275) (275) (275) (275) 1,133 1,133
Balance (in shares) at Sep. 30, 2018 135,140,269 100 135,140,000 0                
Balance at Sep. 30, 2018 $ 887,568 $ 887,568 $ 135 $ 0 $ 477,822 $ 964,683 $ 296,635 $ (190,091) $ 774,592 $ 774,592 $ 112,976 $ 112,976